Cite
HARVARD Citation
Freemantle, N. et al. (2022). Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%. Therapeutic advances in medical oncology. p. . [Online].